cyc 202 has been researched along with butein in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (butein) | Trials (butein) | Recent Studies (post-2010) (butein) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 171 | 0 | 110 |
| Protein | Taxonomy | cyc 202 (IC50) | butein (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 8 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 0.0046 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.73 | |
| 17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | 7.3 | |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | 6.4 | |
| Beta-secretase 1 | Homo sapiens (human) | 2.37 | |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | 1.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brongel, K; Czarna, A; Holak, TA; Kowalska, K; Orth, M; Popowicz, GM; Rothweiler, U; Stemmann, O; Weber, L | 1 |
1 other study(ies) available for cyc 202 and butein
| Article | Year |
|---|---|
NMR screening for lead compounds using tryptophan-mutated proteins.
Topics: Cyclin-Dependent Kinase 2; Drug Evaluation, Preclinical; Humans; Lead; Ligands; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Point Mutation; Protein Interaction Mapping; Proteins; Proto-Oncogene Proteins c-mdm2; Structure-Activity Relationship; Tryptophan; Tumor Suppressor Protein p53 | 2008 |